Role & perspective
Local users only see their market across every module.
Program
Compound NX-217 · Phase III · EU5 Launch · 2026Workspace: Global Brand Office
Approval queue
MLR, medical and brand sign-offs across global and local artefacts.
UK HCP Launch Deck v3
Requested by Grace Hollis · 2026-02-09 · Approver: Elena Marsh · 🇬🇧 United Kingdom
DE Patient Brochure (final art)
Requested by Sofia Lang · 2026-02-04 · Approver: Global MLR · 🇩🇪 Germany
IT Press Kit
Requested by Chiara Romano · 2026-02-07 · Approver: Global Comms · 🇮🇹 Italy
Master Objection-Handler v2
Requested by Global Marketing · 2026-01-28 · Approver: Medical Affairs
ES Congress Booth Concept
Requested by Lucía Vargas · 2026-02-10 · Approver: Brand Studio · 🇪🇸 Spain
Audit trail
Immutable, time-stamped log of every action across the program.
EMA portal EMA day-120 list of questions received for NX-217.
10 Feb 2026, 09:14 ·
Owen Briggs Uploaded NICE Cost-Effectiveness Model v4.xlsx.
08 Feb 2026, 16:42 ·
System New High-impact risk auto-created on UK Launch Supply.
06 Feb 2026, 11:05 ·
Elena Marsh Approved Global HCP Campaign Toolkit for local adaptation.
03 Feb 2026, 08:30
Julien Moreau Pre-meeting with HAS — likely SMR=Important, ASMR IV target.
29 Jan 2026, 14:22 ·
Markus Hahn AMNOG dossier locked and sent to G-BA.
25 Jan 2026, 10:11 ·